Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 3/20 | 0.40 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.40 |
| ▸ | CHEK2 | O96017 | 2/20 | 0.38 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.37 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.37 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | DPP8 | Q6V1X1 | 3/20 | 0.35 |
| ▸ | DPP7 | Q9UHL4 | 3/20 | 0.35 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.35 |
| ▸ | DPP4 | P27487 | 3/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13766538 | 0.82 | CYP2D6 (0.47) | KCNH2DPP8DPP7DPP9DPP4 | |
| SCHEMBL1527345 | 0.82 | CYP2D6 (0.47) | KCNH2DPP8DPP7DPP9DPP4 | |
| SCHEMBL20030334 | 0.80 | CHEK2 (0.40) | CHRNB2CHRNA4CHEK2CHRNB4CHRNA3 | |
| SCHEMBL26999087 | 0.80 | CHEK2 (0.37) | CHRNB2CHRNA4CHEK2CHRNB4CHRNA3 | |
| SCHEMBL17930876 | 0.77 | ATM (0.42) | CHRNB2CHRNA4CHEK2CHRNB4CHRNA3 | |
| SCHEMBL26999088 | 0.77 | ATM (0.42) | CHRNB2CHRNA4CHEK2CHRNB4CHRNA3 | |
| SCHEMBL13762277 | 0.76 | CHEK2 (0.38) | CHRNB2CHRNA4CHEK2CHRNB4CHRNA3 | |
| SCHEMBL13624757 | 0.76 | CHEK2 (0.38) | CHRNB2CHRNA4CHEK2CHRNB4CHRNA3 | |
| Hydrochloric Acid SCHEMBL28060420 | 0.76 | CHEK2 (0.38) | CHRNB2CHRNA4CHEK2CHRNB4CHRNA3 | |
| SCHEMBL26999090 | 0.75 | CHEK2 (0.37) | CHRNB2CHRNA4CHEK2CHRNB4CHRNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7557110-B2 | MAPKAP-K2; inflammatory disease, autoimmune disease, destructive bone disorder, cancer and/or tumour growth; 5-[(trans-4-aminocyclohexyl)amino]-3-fluoro-6-methyl(pyrazolo[1,5-a]pyri- midin-7-yl)}(4-iodophenyl)amine | TEIJIN PHARMA LIMITED (JP) | 2009-07-07 | — | — | US | disclosed |